Becton Dickinson and Co
NYSE:BDX
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
221.47
247.73
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Becton Dickinson and Co
Becton Dickinson and Co
Cash & Cash Equivalents
Becton Dickinson and Co
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash & Cash Equivalents
$1.7B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
26%
|
CAGR 10-Years
-1%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash & Cash Equivalents
$2.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
55%
|
CAGR 10-Years
26%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Cash & Cash Equivalents
$3.7B
|
CAGR 3-Years
35%
|
CAGR 5-Years
25%
|
CAGR 10-Years
25%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash & Cash Equivalents
$3.9B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash & Cash Equivalents
$7B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash & Cash Equivalents
$2.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
20%
|
CAGR 10-Years
17%
|
|
Becton Dickinson and Co
Glance View
Becton Dickinson and Co. (BD) is a global leader in the medical technology sector, with a rich history tracing back to its founding in 1897. The company specializes in the development, manufacturing, and distribution of a wide array of medical devices, instrument systems, and reagents that are essential in hospitals and laboratories. BD's products play a pivotal role in improving patient outcomes by enhancing the accuracy of diagnostics and facilitating efficient pharmaceutical delivery. With a commitment to innovation, BD invests significantly in research and development, ensuring it remains at the forefront of advanced technology in healthcare, which resonates well with investors seeking sustainable growth in a resilient industry. The company's diverse portfolio spans three main segments: BD Medical, BD Life Sciences, and BD Biosciences, enabling it to tap into multiple revenue streams while addressing critical healthcare needs worldwide. BD's strategic focus on expanding its presence in emerging markets, coupled with its robust pipeline of new products, positions it favorably for future growth. Additionally, BD’s commitment to operational excellence and cost management bolsters its profitability and shareholder value. For investors, BD offers a compelling opportunity as it navigates the evolving landscape of healthcare, characterized by increasing demand for high-quality medical solutions and a growing emphasis on personalized medicine. As the company continues to deliver innovative products and services while maintaining strong financial fundamentals, it remains a key player to watch in the dynamic world of medical technology.
See Also
What is Becton Dickinson and Co's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.7B
USD
Based on the financial report for Sep 30, 2024, Becton Dickinson and Co's Cash & Cash Equivalents amounts to 1.7B USD.
What is Becton Dickinson and Co's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-1%
Over the last year, the Cash & Cash Equivalents growth was 21%. The average annual Cash & Cash Equivalents growth rates for Becton Dickinson and Co have been -9% over the past three years , 26% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet
